Cancer cachexia is a multiorganic syndrome associated with neoplastic syndromes, characterized by a marked weight loss, anorexia, asthenia and anemia. This expertly authored book provides a comprehensive review of the mechanisms, mediators and treatment of cancer cachexia. A range of relevant clinical issues are addressed, including prevalence and clinical features of the cachectic syndrome in cancer patients, pathogenesis of the syndrome, and currently available therapeutic approaches including combination therapies. There is also an analysis of the drugs currently involved in clinical trials that may have a future potential. The final chapter deals with comorbidities and prognosis. The book represents a comprehensive expert review and summary of the current status of cancer cachexia and its therapy.